Dosage and Administration (2.3) 4/2024 Indications and Usage for Evenity Injection EVENITY is a sclerostin inhibitor indicated for the treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or...
Two 105 mg/1.17 mL single-use prefilled syringes are required to administer the recommended 210 mg dose of EVENITY [seeDOSAGE AND ADMINISTRATION]. Each single-use prefilled syringe delivers 1.17 mL of a solution containing 105 mg of romosozumab-aqqg, acetate (3.8 mg), calcium (0.61 mg), ...
Find information on Romosozumab (Evenity) in Davis’s Drug Guide including dosage, side effects, interactions, nursing implications, mechanism of action, half life, administration, and more. Davis Drug Guide PDF.